Despite the Effect of Smoking Cessation Limiting Growth in the Number of Non-Small-Cell Lung Cancer (NSCLC) Cases, the Drug Market for NSCLC Will Increase to More Than $6 Billion in 2021, Fueled Largely by the Entry of Seven